1-3 of 3
Eileen Sickle
Close
Sort by
Journal Articles

Prospective Phase II Multicenter Study of Conditioning with Treosulfan, Fludarabine and Low-Dose (2 Gy) Total Body Irradiation Followed by Hematopoietic Cell Transplantation From Related or Unrelated Donors for Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Boglarka Gyurkocza, M.D., Jonathan Gutman, MD, Eneida R. Nemecek, MD, Eileen Sickle, RN, Merav Bar, MD, Joachim Baumgart, PhD, Colleen Delaney, MD, MSc, Barry Storer, PhD, Frederick R. Appelbaum, MD, H. Joachim Deeg, MD
Journal: Blood
Blood (2012) 120 (21): 963.
https://doi.org/10.1182/blood.V120.21.963.963
Published: 2012
Journal Articles

131I–anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission

Clinical Trials & Observations
John M. Pagel, Frederick R. Appelbaum, Janet F. Eary, Joseph Rajendran, Darrell R. Fisher, Ted Gooley, Katherine Ruffner, Eneida Nemecek, Eileen Sickle, Larry Durack, Jeanette Carreras, Mary M. Horowitz, Oliver W. Press, Ajay K. Gopal, Paul J. Martin, Irwin D. Bernstein, Dana C. Matthews
Journal: Blood
Blood (2006) 107 (5): 2184–2191.
https://doi.org/10.1182/blood-2005-06-2317
Published: 2006
Journal Articles

131 I-Anti-CD45 Antibody Plus Busulfan/Cyclophosphamide in Matched Related Transplants for Acute Myeloid Leukemia in First Remission.

John M. Pagel, MD, PhD, Frederick R. Appelbaum, MD, Janet F. Eary, MD, Joseph G. Rajendran, MD, Darrell R. Fisher, PhD, Ted Gooley, PhD, Eneida Nemecek, MD, Katherine Ruffner, MD, Eileen Sickle, RN, Larry Durack, CNMT, Jeanette Carreras, MPH, Mary M. Horowitz, MD, MS, Ajay K. Gopal, MD, Oliver W. Press, MD, PhD, Paul J. Martin, MD, Irwin D. Bernstein, MD, Dana C. Matthews, MD
Journal: Blood
Blood (2004) 104 (11): 813.
https://doi.org/10.1182/blood.V104.11.813.813
Published: 2004